ZK-261991

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameZK-261991

Drug Alias NameZK-991ZK-261991

ClassificationSmall molecules

Mechanisms of ActionStem cell growth factor receptor inhibitorsVascular endothelial growth factor receptor 3 antagonistsAnticancer protein kinase inhibitors +[4]

TargetsVascular endothelial growth factor receptor 3Vascular endothelial growth factor receptor 2Stem cell growth factor receptor

Therapy Area/IndicationsGraft vs Host DiseaseNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBayer Schering Pharma AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBayer Schering Pharma AG

Active IndicationsN/A

Inactive IndicationsGraft vs Host DiseaseNeoplasms

Other Information

ATC CodeN/A